December 8, 2020
While some COVID-19 patients can get very sick, others have barely any symptoms at all. A collaborative study between scientists at Stanford University and the Proteomics and Metabolomics Facility at the Cornell Institute of Biotechnology found that mildly and severely ill patients had different antibody signatures.
October 30, 2020
A brief descriptions of accomplishments for Monica Franciscus, Lynn Johnson, Zack Miller, Yaw Nti-Addae (5 years of service); Sara Miller, Jennifer Mosher, Elodie Smith (10 years); John Flaherty, Xiaoyun Wang (15 years); Cindy Wang (20 years); James VanEe (25 years).
September 18, 2020
New tools to study glycoproteins were created by Matt DeLisa, director of the Cornell Institute of Biotechnology, and his colleagues.
September 3, 2020
The study's objectives were to describe the serum proteome of newborn calves before and after colostrum feeding, and the possible effects of colostral heat treatment. Calves' innate immune defense pathways show important differences associated with colostrum ingestion. They also show that calves fed with heat-treated colostrum showed differences in serum proteins and enzymes associated with carbohydrate metabolism.
June 22, 2020
All BRC facilities are now approved to resume services. We will share detailed changes to procedures, and timelines for the availability of services as soon as possible through mailings and on this website. We look forward to serving our research community as we move to a new (and evolving) normal during this phased process. The safety of our staff and the researchers who depend on our services is paramount. Throughout it all, we kindly ask for your continued patience and understanding.
May 18, 2020
Congratulations to Sheng Zhang and Robert Sherwood from our Proteomics and Metabolomics Facility for their contribution to this breakthrough on #COVID19 research.